What is the price target for SBC stock?
6 analysts have analysed SBC and the average price target is 8.33 USD. This implies a price increase of 115.25% is expected in the next year compared to the current price of 3.87.
NASDAQ:SBC • US73245B1070
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SBC MEDICAL GROUP HOLDINGS I (SBC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-06 | BTIG | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 193.542M | 205.416M 6.13% | 181.28M -11.75% | 190.95M 5.33% | 209.63M 9.78% | ||
| EBITDA YoY % growth | N/A | 83.316M | 89.162M 7.02% | 85.385M -4.24% | 87.86M 2.90% | N/A | |
| EBIT YoY % growth | -540K | 71.069M 13,260.94% | 85.363M 20.11% | 74.556M -12.66% | 79.004M 5.97% | 82.335M 4.22% | |
| Operating Margin | N/A | 36.72% | 41.56% | 41.13% | 41.37% | 39.28% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.45 -25.49% | 0.50 11.65% | 0.60 19.19% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 -36.21% | 0.10 -51.90% | 0.13 556.50% | 0.13 5.21% | 0.14 12.50% | 0.14 40.00% | 0.14 7.69% | 0.15 20.00% | 0.15 11.11% |
| Revenue Q2Q % growth | 45.896M 3.32% | 45.557M -3.74% | 48.413M 11.66% | 49.13M 13.32% | 50.221M 9.42% | 53.538M 17.52% | 54.434M 12.44% | 54.926M 11.80% | 57.916M 15.32% |
| EBITDA Q2Q % growth | 18.907M -19.80% | 17.705M -28.70% | 23.25M 46.98% | 23.382M 30.69% | 23.523M 24.41% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 18.848M -4.70% | 17.355M -28.29% | 20.628M 41.73% | 20.988M 32.16% | 21.825M 15.79% | N/A | N/A | N/A | N/A |
All data in USD
6 analysts have analysed SBC and the average price target is 8.33 USD. This implies a price increase of 115.25% is expected in the next year compared to the current price of 3.87.
SBC MEDICAL GROUP HOLDINGS I (SBC) will report earnings on 2026-03-27, before the market open.
The consensus EPS estimate for the next earnings of SBC MEDICAL GROUP HOLDINGS I (SBC) is 0.12 USD and the consensus revenue estimate is 45.90M USD.
The consensus rating for SBC MEDICAL GROUP HOLDINGS I (SBC) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.